{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T06:43:33Z","timestamp":1782456213280,"version":"3.54.5"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2021,10,5]],"date-time":"2021-10-05T00:00:00Z","timestamp":1633392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,5]],"date-time":"2021-10-05T00:00:00Z","timestamp":1633392000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Pediatr"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s12098-021-03892-5","type":"journal-article","created":{"date-parts":[[2021,10,6]],"date-time":"2021-10-06T00:20:11Z","timestamp":1633479611000},"page":"1203-1208","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Management of Short Stature: Use of Growth Hormone in GH-Deficient and non-GH\u2013Deficient Conditions"],"prefix":"10.1007","volume":"88","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1927-0487","authenticated-orcid":false,"given":"Varuna","family":"Vyas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ram K.","family":"Menon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,5]]},"reference":[{"key":"3892_CR1","doi-asserted-by":"crossref","unstructured":"Ayyar VS. History of growth hormone therapy. Indian J Endocrinol Metab. 2011;15 Suppl 3:S162\u20135.","DOI":"10.4103\/2230-8210.84852"},{"key":"3892_CR2","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1159\/000452150","volume":"86","author":"A Grimberg","year":"2016","unstructured":"Grimberg A, Divall SA, Polychronakos C, et al. Guidelines for growth hormone and insulin-like growth factor-I treatment in children and adolescents: growth hormone deficiency, idiopathic short stature, and primary insulin-like growth factor-I deficiency. Horm Res Paediatr. 2016;86:361\u201397.","journal-title":"Horm Res Paediatr"},{"key":"3892_CR3","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s12098-010-0090-5","volume":"77","author":"MK Garg","year":"2010","unstructured":"Garg MK, Pakhetra R, Dutta MK, Gundgurthi A. Response to growth hormone therapy in Indian patients. Indian J Pediatr. 2010;77:639\u201342.","journal-title":"Indian J Pediatr"},{"key":"3892_CR4","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1210\/jc.2005-2284","volume":"91","author":"EO Reiter","year":"2006","unstructured":"Reiter EO, Price DA, Wilton P, Albertsson-Wikland K, Ranke MB. Effect of growth hormone (GH) treatment on the near-final height of 1258 patients with idiopathic GH deficiency: analysis of a large international database. J Clin Endocrinol Metab. 2006;91:2047\u201354.","journal-title":"J Clin Endocrinol Metab"},{"key":"3892_CR5","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1159\/000184154","volume":"42","author":"MB Ranke","year":"1994","unstructured":"Ranke MB, Grauer ML. Adult height in Turner syndrome: results of a multinational survey 1993. Horm Res. 1994;42:90\u20134.","journal-title":"Horm Res"},{"key":"3892_CR6","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/EJE-17-0430","volume":"177","author":"CH Gravholt","year":"2017","unstructured":"Gravholt CH, Andersen NH, Conway GS, et al. Clinical practice guidelines for the care of girls and women with turner syndrome: proceedings from the 2016 cincinnati international turner syndrome meeting. Eur J Endocrinol. 2017;177:G1\u201370.","journal-title":"Eur J Endocrinol"},{"key":"3892_CR7","doi-asserted-by":"crossref","unstructured":"Darendeliler F, Karagiannis G, Wilton P. Headache, idiopathic intracranial hypertension and slipped capital femoral epiphysis during growth hormone treatment: a safety update from the KIGS database. Horm Res. 2007;68 Suppl 5:41\u20137.","DOI":"10.1159\/000110474"},{"key":"3892_CR8","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1210\/jc.2009-0178","volume":"95","author":"J Bell","year":"2010","unstructured":"Bell J, Parker KL, Swinford RD, Hoffman AR, Maneatis T, Lippe B. Long-term safety of recombinant human growth hormone in children. J ClinEndocrinolMetab. 2010;95:167\u201377.","journal-title":"J ClinEndocrinolMetab"},{"key":"3892_CR9","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/s41581-019-0161-4","volume":"15","author":"J Drube","year":"2019","unstructured":"Drube J, Wan M, Bonthuis M, et al. clinical practice recommendations for growth hormone treatment in children with chronic kidney disease. Nat Rev Nephrol. 2019;15:577\u201389.","journal-title":"Nat Rev Nephrol"},{"key":"3892_CR10","doi-asserted-by":"crossref","unstructured":"W\u00fchl E, Haffner D, Nissel R, Schaefer F, Mehls O. Short dialyzed children respond less to growth hormone than patients prior to dialysis. German study group for growth hormone treatment in chronic renal failure. Pediatr Nephrol. 1996;10:294\u20138.","DOI":"10.1007\/BF00866763"},{"key":"3892_CR11","doi-asserted-by":"crossref","unstructured":"Vimalachandra D, Hodson EM, Willis NS, Craig JC, Cowell C, Knight JF. Growth hormone for children with chronic kidney disease. Cochrane Database Syst Rev. 2006;19:CD003264.","DOI":"10.1002\/14651858.CD003264.pub2"},{"key":"3892_CR12","first-page":"2816","volume":"85","author":"F de Zegher","year":"2000","unstructured":"de Zegher F, Albertsson-Wikland K, Wollmann HA, et al. Growth hormone treatment of short children born small for gestational age: growth responses with continuous and discontinuous regimens over 6 years. J ClinEndocrinolMetab. 2000;85:2816\u201321.","journal-title":"J ClinEndocrinolMetab"},{"key":"3892_CR13","doi-asserted-by":"crossref","unstructured":"Lee PA, Chernausek SD, Hokken-Koelega AC, Czernichow P. International Small for Gestational Age Advisory Board. International small for gestational age advisory board consensus development conference statement: management of short children born small for gestational age, April 24-October 1, 2001. Pediatrics. 2003;111:1253\u201361.","DOI":"10.1542\/peds.111.6.1253"},{"key":"3892_CR14","doi-asserted-by":"publisher","first-page":"e519","DOI":"10.1542\/peds.2009-0293","volume":"124","author":"A Maiorana","year":"2009","unstructured":"Maiorana A, Cianfarani S. Impact of growth hormone therapy on adult height of children born small for gestational age. Pediatrics. 2009;124:e519\u201331.","journal-title":"Pediatrics"},{"key":"3892_CR15","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1542\/peds.2010-2820","volume":"127","author":"McCandless SE; Committee on Genetics","year":"2011","unstructured":"McCandless SE; Committee on Genetics. Clinical report\u2014health supervision for children with Prader-Willi syndrome. Pediatrics. 2011;127:195\u2013204.","journal-title":"Pediatrics"},{"key":"3892_CR16","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.1016\/S0022-3476(97)70008-8","volume":"131","author":"DB Allen","year":"1997","unstructured":"Allen DB, Rundle AC, Graves DA, Blethen SL. Risk of leukemia in children treated with human growth hormone: review and reanalysis. J Pediatr. 1997;131:S32\u20136.","journal-title":"J Pediatr"},{"key":"3892_CR17","doi-asserted-by":"crossref","unstructured":"Nishi Y, Tanaka T, Takano K, et al. Recent status in the occurrence of leukemia in growth hormone-treated patients in Japan.GH treatment study committee of the foundation for growth science, Japan. J Clin Endocrinol Metab. 1999;84:1961\u20135.","DOI":"10.1210\/jcem.84.6.5716"},{"key":"3892_CR18","unstructured":"Teramoto A. Growth hormone therapy and brain tumors. Pediatr Endocrinol Rev. 2017;14Suppl 1(Suppl 1):229\u201334."},{"key":"3892_CR19","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1210\/jc.2015-1002","volume":"100","author":"S Raman","year":"2015","unstructured":"Raman S, Grimberg A, Waguespack SG, et al. Risk of neoplasia in pediatric patients receiving growth hormone therapy\u2013a report from the pediatric endocrine society drug and therapeutics committee. J Clin Endocrinol Metab. 2015;100:2192\u2013203.","journal-title":"J ClinEndocrinolMetab"},{"key":"3892_CR20","doi-asserted-by":"publisher","first-page":"146","DOI":"10.4274\/jcrpe.galenos.2020.2020.0007","volume":"13","author":"N Mart\u00edn-Begu\u00e9","year":"2021","unstructured":"Mart\u00edn-Begu\u00e9 N, Mogas E, WolleyDod C, et al. Growth hormone treatment and papilledema: a prospective pilot study. J Clin Res Pediatr Endocrinol. 2021;13:146\u201351.","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"3892_CR21","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1210\/jc.2011-1995","volume":"97","author":"JC Carel","year":"2012","unstructured":"Carel JC, Ecosse E, Landier F, et al. Long-term mortality after recombinant growth hormone treatment for isolated growth hormone deficiency or childhood short stature: preliminary report of the French SAGhE study. J Clin Endocrinol Metab. 2012;97:416\u201325.","journal-title":"J Clin Endocrinol Metab"},{"key":"3892_CR22","doi-asserted-by":"crossref","unstructured":"Tidblad A, Bottai M, Kieler H, Albertsson-WiklandK, S\u00e4vendahl L. Association of childhood growth hormone treatment with long-term cardiovascular morbidity. JAMA Pediatr.\u00a02021;175:e205199.","DOI":"10.1001\/jamapediatrics.2020.5199"},{"key":"3892_CR23","doi-asserted-by":"publisher","DOI":"10.1007\/s12098-021-03824-3","author":"R Saroufim","year":"2021","unstructured":"Saroufim R, Eugster EA. Non-GH Agents and Novel Therapeutics in the Management of Short Stature. Indian J Pediatr. 2021. https:\/\/doi.org\/10.1007\/s12098-021-03824-3.","journal-title":"Indian J Pediatr"}],"container-title":["Indian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12098-021-03892-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12098-021-03892-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12098-021-03892-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,15]],"date-time":"2021-11-15T11:22:57Z","timestamp":1636975377000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12098-021-03892-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,5]]},"references-count":23,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["3892"],"URL":"https:\/\/doi.org\/10.1007\/s12098-021-03892-5","relation":{},"ISSN":["0019-5456","0973-7693"],"issn-type":[{"value":"0019-5456","type":"print"},{"value":"0973-7693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,5]]},"assertion":[{"value":"18 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}